Analysts at Tokyo-based investment banking firm Mizuho Securities suggest Amazon’s only viable entry into the drugstore retailer industry would be through the acquisition of a major retailer. While Woonsocket, R.I.-based CVS and Deerfield, Ill.-based Walgreens would constitute “monster deals” for the online retailer, analysts said the acquisition of Camp Hill, Pa.-based Rite Aid “is a real possibility,” according to the report.
The Federal Trade Commission is expected to issue a decision on the Rite Aid-Walgreens merger in July. Some experts, however, are skeptical the agency will approve the deal.
If the deal ends up in litigation, it could be another year or more before Amazon could negotiate a potential acquisition of Rite Aid, according to the report.
More articles on transactions and valuations:
Elliot Health System, Southern New Hampshire Health sign letter of intent to combine operations
Summit Health acquires Pennsylvania family practice
WVU Medicine, Highlands Hospital partner to open heart clinic
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
